Guanhao Biotech Co.,Ltd. (SZSE: 300238)
Health Care · Biotechnology · CN
CN¥11.95
-0.33% today · -21.7% 1Y
Guanhao Biotech Co.,Ltd. (SZSE: 300238) operates in the Biotechnology industry within the Health Care sector. The company is valued at $489.37M and employs 535 people.
Over the last twelve months the share price has lost 21.7%, trading between 10.19 and 18.00.
Tweenvest scores Guanhao Biotech Co.,Ltd. across four factors: quality 75/100, value 18/100, growth 16/100. Its strongest factor is quality.
300238 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $489.37M
- Revenue (TTM)
- $53.20M
- P/E
- 191.53
- EPS
- 0.06
- Dividend yield
- —
- Beta (5Y)
- 0.17
- 52-week high
- CN¥18.00
- 52-week low
- CN¥10.19
- Avg volume (3M)
- —
- Shares outstanding
- 274.70M
- Employees
- 535
- Next earnings
- —
About Guanhao Biotech Co.,Ltd.
Guanhao Biotech Co.,Ltd. is a Chinese enterprise dedicated to the research, production, and marketing of regenerative medicine solutions. Its product portfolio encompasses NormalGEN, a biological dura repair patch crafted from animal tissue, and GrandNeuro, an artificial alternative for dura restoration. For broader surgical applications, the company offers ThormalGEN, another biological surgical patch also derived from animal tissue. DermalGEN, an animal tissue-based wound dressing, is designed for treating burns, scalds, and skin injuries resulting from loss or trauma. Additionally, Guanhao Biotech markets the IREAL breast patch. The company was established in 1999 and is headquartered in Guangzhou, China.
- ISIN
- CNE100001575
- Founded
- 1999
- Listed since
- Jul 6, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai Bao Pharmaceuticals Co., Ltd.SEHK: 2659 | $497.68M | HK$12.08 | -4.88% |
| Entera Bio Ltd.NasdaqCM: ENTX | $495.19M | $2.50 | -12.59% |
| Allogene Therapeutics, Inc.NasdaqGS: ALLO | $494.05M | $1.40 | -2.10% |
| Beijing Leadman Biochemistry Co.,Ltd.SZSE: 300289 | $491.47M | CN¥6.06 | +2.02% |
| Bright Minds Biosciences Inc.CNSX: DRUG | $488.45M | CA$73.52 | +4.15% |
| ACRO Biomedical Co., Ltd.TPEX: 6748 | $486.06M | NT$216.00 | -5.26% |
| Qyuns Therapeutics Co., Ltd.SEHK: 2509 | $483.91M | HK$17.00 | +1.37% |
| Autolus Therapeutics plcNasdaqGS: AUTL | $481.75M | $1.77 | -2.21% |
Figures last refreshed Oct 4, 2026.